Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,904 | -2,351 | -6,935 | -4,301 | -2,095 |
| Depreciation Amortization | 472 | 235 | 898 | 655 | 428 |
| Accounts receivable | 21 | -40 | 47 | 631 | 192 |
| Other Working Capital | 144 | 9 | -174 | -647 | 163 |
| Other Operating Activity | 21 | 82 | 10 | -601 | -162 |
| Operating Cash Flow | $-4,246 | $-2,065 | $-6,154 | $-4,263 | $-1,474 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 891 | 921 | 6,472 | 4,122 | 4,151 |
| PPE Investments | -87 | -60 | -336 | -332 | -306 |
| Other Investing Activity | 0 | 0 | -209 | 0 | 0 |
| Investing Cash Flow | $804 | $861 | $5,927 | $3,790 | $3,845 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -249 | -225 | -784 | -730 | -717 |
| Other Financing Activity | 9,130 | 9,035 | 266 | 219 | 189 |
| Financing Cash Flow | $8,881 | $8,810 | $-518 | $-511 | $-528 |
| Exchange Rate Effect | -18 | 23 | 28 | -14 | 3 |
| Beginning Cash Position | 727 | 727 | 1,444 | 1,444 | 1,444 |
| End Cash Position | 6,148 | 8,356 | 727 | 446 | 3,290 |
| Net Cash Flow | $5,421 | $7,629 | $-717 | $-998 | $1,846 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,246 | -2,065 | -6,154 | -4,263 | -1,474 |
| Capital Expenditure | -87 | -60 | -336 | -332 | -306 |
| Free Cash Flow | -4,333 | -2,125 | -6,490 | -4,595 | -1,780 |